Good results for ovarian cancer drug

Israel’s Biocancell Therapeutics announced that phase 1/II(a) trials have proved BC-819 to be safe and effective in treating ovarian cancer.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000733108&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.